Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for producing recombinant human bone morphogenetic protein-2 mature peptide

A morphogenetic protein and production method technology, applied in the field of protein purification, can solve problems such as the inability to achieve efficient industrial production

Active Publication Date: 2012-02-01
HANGZHOU JIUYUAN GENE ENG
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] In order to solve the technical defect that the production of recombinant human bone morphogenetic protein-2 (rhBMP-2) mature peptide cannot realize efficient industrial production in the prior art, the present invention provides a method different from the above-mentioned method, which is easy to operate, low in cost, suitable for Separation and purification method for large-scale scale-up production of high-purity and high-activity recombinant human bone morphogenetic protein-2 mature peptide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for producing recombinant human bone morphogenetic protein-2 mature peptide
  • Method for producing recombinant human bone morphogenetic protein-2 mature peptide
  • Method for producing recombinant human bone morphogenetic protein-2 mature peptide

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0037] Example 1 Solubilization of inclusion bodies

[0038] Dissolve the inclusion bodies in the lysate (7M guanidine hydrochloride, 50mM Tris-HCl, pH8.0, 1mM EDTA, 10mM DTT) at a ratio of 1 gram of inclusion body: 20mL of lysate, and stir at room temperature for more than 2 hours or at 4°C overnight. Then centrifuge at 12000rpm and 4°C for 20min, discard the precipitate and take the centrifugation supernatant. Protein concentration was determined by Bradford method.

[0039]Or solubilize by the following method. Dissolve inclusion bodies in lysate (8M urea, 50mM Tris-HCl, pH8.5, 1mM EDTA, 10mM DTT) at a ratio of 1 gram of inclusion body: 20mL of lysate, and stir at room temperature for more than 2 hours or overnight at 4°C . Then centrifuge at 12000rpm and 4°C for 20min, discard the precipitate and take the centrifugation supernatant. Protein concentration was determined by Bradford method.

example 2

[0040] Example 2 Renaturation of Inclusion Body

[0041] Refolding by dilution method. The refolding solution consists of: 100mM Tris-HCl, 0.5M L-Arg, 0.5M Urea, 1M NaCl, 2mM EDTA, pH8.5-9.5, 1mM oxidized glutathione, 5mM reduced glutathione. Slowly add the inclusion body enhancement solution into the refolding solution, control the final protein concentration to 0.05-0.3 mg / mL, and refold under a constant temperature environment of 4-20 degrees for 1-20 days.

example 3

[0042] The hydrophobic interaction chromatography of example 3 refolding solution

[0043] Firstly, hydrophobic interaction chromatography with low salt concentration is used, the chromatography filler is phenylsepharose Fast Flow, and the equilibrium solution is phe-A: 0.5M urea, 25mM CHES, 15mM Tris, pH8.5, 5% N, N-dimethylformamide , 1M NaCl. The eluent was phe-B: 0.5Murea, 25mM CHES, 15mM Tris, pH 8.5, 5% N,N-dimethylformamide. First, use the balance solution phe-A to balance, and the refolding solution to directly load the sample. After the sample is loaded, continue to wash with the balance buffer phe-A until the UV reaches the baseline, and then use the elution buffer phe-B to gradually reduce the salt concentration. Elution was performed and the main peak was collected.

[0044] In order to further improve the purity, the hydrophobic interaction chromatography with high salt concentration can continue to be used for collecting the main peak. The chromatographic fill...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Conductivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for producing recombinant human bone morphogenetic protein-2 mature peptide. The method comprises the following steps: sampling a recombinant human bone morphogenetic protein-2 mature peptide solution with good renaturation into a balanced hydrophobic chromatography column, then performing a stepped-gradient elution which gradually reduces the salinity by an elution buffer solution, and collecting target peaks. In order to further enhance the protein purity of the target peaks, the purification method can be a multi-step hydrophobic interaction chromatography or be used by combining with the ion exchange chromatography. The method has the advantages of simple operation, lower cost, higher purification yield (more than 20%), higher purity (SDS-PAGE, HPLC and HPCE are greater than 97%) and the like, and is suitable for producing the recombinant human bone morphogenetic protein family.

Description

technical field [0001] The invention relates to the field of protein purification, in particular to a method for purifying and producing recombinant human bone morphogenetic protein-2 (rhBMP-2) mature peptide. Background technique [0002] In 1965, American doctor Urist (Urist MR. Bone: formation byautoinduction. Science, 1965, 150 (698): 893-899) found that the decalcified bone mesenchyme has ectopic osteogenesis, and the newly discovered ability to induce new The protein of bone formation is named bone morphogenetic protein (Bone Morphogenetic protein, BMP). Subsequently, many BMPs were discovered, except for BMP-1, they are all members of the TGF-beta superfamily, and they are very similar in gene or protein structure, or in biological function. Among them, the osteogenesis of BMP-2 is the most researched, and the industrialization research is also the most extensive. [0003] The full length of human BMP-2 is 396 amino acid residues, and the mature peptide with osteoge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/47C07K1/20C07K1/18
Inventor 郭旺明朱晴羽王同映
Owner HANGZHOU JIUYUAN GENE ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com